DEXIS Reflects on a Year of Innovation and Unveils Exciting Plans for 2025
DEXIS, a dental imaging technologies leader, reflects on its 2024 achievements and announces plans for 2025. Key 2024 launches included the DEXIS digital ecosystem for streamlined implant workflow, the Ti2 Intraoral Sensor with AI capabilities, DEXIS Connect Pro for proactive device monitoring, and the ORTHOPANTOMOGRAPH OP 3D EX X-ray platform.
The company plans several innovations for 2025, including their first in-house developed intraoral scanner, AI enhancements, 3D imaging portfolio expansion, and DTX Studio Clinic workflow updates. These developments will be showcased at the Chicago Dental Society Midwinter Meeting in February and the International Dental Show in Cologne in March. Currently, over 150,000 DEXIS dental imaging devices are in use worldwide.
DEXIS, leader nelle tecnologie di imaging dentale, riflette sui risultati del 2024 e annuncia piani per il 2025. Tra i lanci chiave del 2024 c’erano il DEXIS digital ecosystem per un flusso di lavoro degli impianti semplificato, il Ti2 Intraoral Sensor con capacità AI, DEXIS Connect Pro per il monitoraggio proattivo dei dispositivi e la piattaforma radiografica ORTHOPANTOMOGRAPH OP 3D EX.
La compagnia prevede diverse innovazioni per il 2025, inclusi il loro primo scanner intraorale sviluppato internamente, migliorie con AI, un’espansione del portafoglio di imaging 3D e aggiornamenti al flusso di lavoro di DTX Studio Clinic. Questi sviluppi saranno presentati al Chicago Dental Society Midwinter Meeting a febbraio e all'International Dental Show a Colonia a marzo. Attualmente, oltre 150.000 dispositivi di imaging dentale DEXIS sono in uso in tutto il mondo.
DEXIS, líder en tecnologías de imagen dental, reflexiona sobre sus logros de 2024 y anuncia planes para 2025. Los lanzamientos clave de 2024 incluyeron el ecosistema digital DEXIS para un flujo de trabajo de implantes simplificado, el Sensor Intraoral Ti2 con capacidades de IA, DEXIS Connect Pro para la monitorización proactiva de dispositivos, y la plataforma de rayos X ORTHOPANTOMOGRAPH OP 3D EX.
La empresa planea varias innovaciones para 2025, incluyendo su primer escáner intraoral desarrollado internamente, mejoras con IA, expansión del portafolio de imágenes 3D y actualizaciones del flujo de trabajo de DTX Studio Clinic. Estos desarrollos se mostrarán en la Reunión de Invierno de la Sociedad Dental de Chicago en febrero y en el International Dental Show en Colonia en marzo. Actualmente, hay más de 150,000 dispositivos de imagen dental DEXIS en uso en todo el mundo.
DEXIS는 치과 영상 기술의 선두주자로서 2024년 성과를 되돌아보고 2025년 계획을 발표합니다. 2024년의 주요 출시에는 임플란트 워크플로우를 간소화하기 위한 DEXIS 디지털 생태계, AI 기능을 갖춘 Ti2 인트라오랄 센서, 장치 모니터링을 위한 DEXIS Connect Pro, 그리고 ORTHOPANTOMOGRAPH OP 3D EX 엑스레이 플랫폼이 포함됩니다.
회사는 2025년을 위해 여러 혁신을 계획 중이며, 여기에는 자체 개발한 첫 인트라오랄 스캐너, AI 향상, 3D 영상 포트폴리오 확장 및 DTX Studio Clinic 워크플로우 업데이트가 포함됩니다. 이러한 개발은 2월 시카고 치과 학회 중간 회의와 3월 쾰른 국제 치과 전시회에서 공개될 예정입니다. 현재 전 세계적으로 150,000개 이상의 DEXIS 치과 영상 장치가 사용되고 있습니다.
DEXIS, leader en technologies d'imagerie dentaire, fait le point sur ses réalisations de 2024 et annonce ses projets pour 2025. Les lancements clés de 2024 incluent l'écosystème numérique DEXIS pour un workflow d'implant simplifié, le capteur intraoral Ti2 avec fonctionnalités d'IA, DEXIS Connect Pro pour la surveillance proactive des dispositifs, et la plateforme de rayons X ORTHOPANTOMOGRAPH OP 3D EX.
L'entreprise prévoit plusieurs innovations pour 2025, y compris son premier scanner intraoral développé en interne, des améliorations basées sur l'IA, une extension de son portefeuille d'imagerie 3D et des mises à jour du workflow DTX Studio Clinic. Ces développements seront présentés lors de la réunion d'hiver de la Chicago Dental Society en février et lors du Salon international dentaire de Cologne en mars. Actuellement, plus de 150 000 dispositifs d'imagerie dentaire DEXIS sont utilisés dans le monde entier.
DEXIS, ein führendes Unternehmen für dental imaging Technologien, blickt auf seine Erfolge im Jahr 2024 zurück und kündigt Pläne für 2025 an. Zu den wichtigsten Produktneuheiten im Jahr 2024 gehören das DEXIS digitale Ökosystem für einen optimierten Implantat-Workflow, der Ti2 Intraoral-Sensor mit KI-Funktionen, DEXIS Connect Pro für proaktive Gerätemonitoring und die ORTHOPANTOMOGRAPH OP 3D EX Röntgenplattform.
Das Unternehmen plant mehrere Innovationen für 2025, darunter den ersten intern entwickelten intraoralen Scanner, KI-Verbesserungen, eine Erweiterung des 3D-Bildportfolios und Aktualisierungen des DTX Studio Clinic Workflows. Diese Entwicklungen werden im Februar auf dem Midwinter Meeting der Chicago Dental Society und im März auf der International Dental Show in Köln präsentiert. Derzeit sind weltweit über 150.000 DEXIS dental imaging Geräte im Einsatz.
- Successful launch of multiple innovative products in 2024
- Large installed base with over 150,000 devices worldwide
- Expanding product portfolio with new intraoral scanner development
- Strategic AI integration across product ecosystem
- None.
QUAKERTOWN, PENNSYLVANIA / ACCESS Newswire / February 3, 2025 / DEXIS, an international leader in dental imaging technologies, celebrates the 2024 launch of its DEXIS digital ecosystem along with other AI-powered imaging solutions. The company also announces that 2025 will bring further innovations, with presentations at two major dental technology conferences.
"For DEXIS, 2024 was a year of tremendous innovation, as we continue to provide dental professionals with the most powerful, efficient and time-saving diagnostic tools and technologies," DEXIS President Robert Befidi said. "We are proud of our progress and will bring that momentum with us in 2025 as we unveil exciting, industry-changing initiatives."
The company enhanced its portfolio of award-winning imaging solutions in 2024, beginning with the February 2024 launch of the DEXIS digital ecosystem, a suite of tools and software designed to connect and streamline the implant workflow. The platform combines cutting-edge CBCT, intraoral scanning, diagnostics, and treatment planning to aid clinicians through their entire digital workflow from diagnosis to delivery. The open imaging system ensures that clinicians have the freedom to customize workflows and that patients, labs, and staff have the appropriate visibility, creating a seamless experience.
May 2024 brought the release of the DEXIS Ti2 Intraoral Sensor, built on the success of its predecessor, the best-selling DEXIS Titanium Sensor. The Ti2 sensor provides high-resolution images while also adding 2D AI Dental Findings, an integrated offering that automatically identifies and highlights 6 common dental findings. The sensor's housing also incorporates subtle design changes that make it more resistant to drops and wear.
In August, the company announced the launch of DEXIS™ Connect Pro, which provides proactive monitoring of DEXIS CBCT and intraoral sensor devices through IoT technology. It connects DEXIS customers with more than 100 DEXIS technical support agents, automatically arranging support, preventative maintenance, or equipment replacements if performance issues are detected. By keeping digital equipment operating without interruption, the Connect Pro solution enhances office productivity and consistent patient care for dental professionals who rely on DEXIS technology.
DEXIS continued to actively improve its solutions with the September 2024 release of the ORTHOPANTOMOGRAPH™ OP 3D™ EX X-ray platform. Designed specifically for general practitioners looking to expand their diagnostic capabilities with 3D imaging, the OP 3D EX has a wide range of field of view sizes to support multiple clinical indications. Updates to the DTX Studio™ Clinic software provided advanced tools and new functionality that allows practitioners to plan an implant treatment and generate a surgical guide chairside, in less than three minutes.
DEXIS envisions 2025 as another year of ground-breaking advancements in technology and customer service. Projects currently in production or development include:
The first intraoral scanner developed entirely by DEXIS
AI enhancements across the ecosystem to increase efficiency and productivity
An exciting innovation within the 3D imaging portfolio
Updates to enhance the implant workflow in DTX Studio Clinic
DEXIS expects to begin rolling out these initiatives at two major 2025 industry meetings: the Chicago Dental Society Midwinter Meeting in February and the International Dental Show in Cologne, Germany, in March.
The Chicago Dental Society meeting, February 20-25 at McCormick Place West, is the organization's 160th annual midwinter conference and offers more than 200 courses on dental medicine. It draws both U.S. and international dental professionals as well as hundreds of exhibitors.
The International Dental Show, March 25-29, is the world's leading trade fair for the dental sector. The biennial event is known as a trend-setting event, where major manufacturers unveil advances in technology for the top decision-makers in dentistry.
As one of the world's leading developers of dental imaging technologies, DEXIS sees both events as essential venues for showcasing its products and connecting with DEXIS owners." There are more than 150,000 DEXIS dental imaging devices in use worldwide which is a testament to our mission to transform practices and patient smiles globally," Befidi said. "Every year, we build on our long tradition of innovation and successes, learn from our lessons, and aim to provide innovative solutions and exceptional service to our customers."
Visit the company's website at www.dexis.com to stay informed about the latest industry news, product information, and upcoming events.
About DEXIS
DEXIS has been a global leading brand in digital radiography for 70+ years. Today, DEXIS has brought together the most trusted brands in 3D imaging, intraoral scanning solutions, and diagnostic software to provide you with a complete digital diagnostic solution under a brand name. Our innovative award-winning technology enhances the way you diagnose, accelerates your workflow, and delivers simpler treatment paths with better patient outcomes. For more information, please visit https://www.dexis.com.
About Envista Holdings Corporation
Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives. Envista helps its customers deliver the best possible patient care through industry-leading dental consumables, solutions, technology, and services. Its comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a wide array of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the aesthetics of the human smile. With a foundation comprised of the proven Envista Business System (EBS) methodology, an experienced leadership team, and a strong culture grounded in continuous improvement, commitment to innovation, and deep customer focus, Envista is well equipped to meet the end-to-end needs of dental professionals worldwide. Envista is one of the largest global dental products companies, with significant market positions in some of the most attractive segments of the dental products industry. For more information, please visit www.envistaco.com.
Contact Information
Maria Penaloza
Media & Content Strategy Manager
maria.penaloza@issuerdirect.com
Julie Hansoulle
Sr. Marketing Manager DEXIS EU
julie.hansoulle@envistaco.com
SOURCE: Envista
View the original press release on ACCESS Newswire
FAQ
What major products did DEXIS launch in 2024?
What new products is DEXIS planning to release in 2025?
How many DEXIS dental imaging devices are currently in use globally?